Nishihara, Reiko
Harvard T.H. Chan School of Public Health,
United States
2025 Rank: 190978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5874 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 190978 | 199025 |
| Total Cites | 1055 | 1162 |
| H-index | 17 | 17 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 93 | 103 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 108 | 124 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 914 | 960 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
9.21%
|
|
Nishihara, Reiko
Harvard Medical School,
United States
2024 Rank: 166059
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5465 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 166059 | 162314 |
| Total Cites | 1101 | 1235 |
| H-index | 16 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 107 | 116 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 132 | 147 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 943 | 990 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.25 |
| Self-Citation Percentage |
10.85%
|
|
Nishihara, Reiko
Harvard T.H. Chan School of Public Health,
United States
2023 Rank: 147426
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5242 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 147426 | 144257 |
| Total Cites | 1249 | 1431 |
| H-index | 19 | 20 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 90 | 102 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 121 | 143 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1045 | 1099 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.30 |
| Self-Citation Percentage |
12.72%
|
|
Nishihara, Reiko
Dana-Farber Cancer Institute,
United States
2022 Rank: 121802
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 4589 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121802 | 117883 |
| Total Cites | 1269 | 1461 |
| H-index | 18 | 20 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 119 | 136 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 152 | 182 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1038 | 1095 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.33 |
| Self-Citation Percentage |
13.14%
|
|
Nishihara, Reiko
Harvard T.H. Chan School of Public Health,
United States
2021 Rank: 120875
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 4310 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 120875 | 122087 |
| Total Cites | 1951 | 2224 |
| H-index | 23 | 25 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 196 | 216 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 249 | 285 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1582 | 1690 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.32 |
| Self-Citation Percentage |
12.28%
|
|
Nishihara, Reiko
Harvard T.H. Chan School of Public Health,
United States
2020 Rank: 106969
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 3712 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106969 | 99784 |
| Total Cites | 1486 | 1740 |
| H-index | 19 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 175 | 188 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 206 | 228 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1185 | 1261 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.38 |
| Self-Citation Percentage |
14.60%
|
|